BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34482348)

  • 1. Differential diagnosis of necrotizing myopathy.
    Selva-O'Callaghan A; Trallero-Araguás E; Milisenda JC; Grau-Junyent JM
    Curr Opin Rheumatol; 2021 Nov; 33(6):544-553. PubMed ID: 34482348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease.
    Nicolau S; Milone M; Tracy JA; Mills JR; Triplett JD; Liewluck T
    Muscle Nerve; 2021 Dec; 64(6):734-739. PubMed ID: 34617293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.
    Qiu R; Wang Z; Wei X; Sui H; Jiang Z; Yu XF
    Biomed Pharmacother; 2022 Dec; 156():113936. PubMed ID: 36411623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y; Benveniste O; Stenzel W; Boyer O
    Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peculiar clinicopathological features of immune-mediated necrotizing myopathies.
    Allenbach Y; Benveniste O
    Curr Opin Rheumatol; 2018 Nov; 30(6):655-663. PubMed ID: 30239349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Is in the Myopathy Literature?
    Al-Lahham T; Lacomis D
    J Clin Neuromuscul Dis; 2022 Sep; 24(1):38-48. PubMed ID: 36005472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acquired necrotizing myopathies].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2013 Jun; 34(6):363-8. PubMed ID: 22998975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
    Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.
    Suzuki S; Uruha A; Suzuki N; Nishino I
    Autoimmun Rev; 2017 Jul; 16(7):693-700. PubMed ID: 28479486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrotizing myopathies: beyond statins.
    Mammen AL
    Curr Opin Rheumatol; 2014 Nov; 26(6):679-83. PubMed ID: 25203117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
    Basharat P; Christopher-Stine L
    Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
    Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
    Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review.
    Mekmangkonthong A; Amornvit J; Numkarunarunrote N; Veeravigrom M; Khaosut P
    Pediatr Rheumatol Online J; 2022 Jun; 20(1):40. PubMed ID: 35672822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
    Mammen AL
    Nat Rev Neurol; 2011 Jun; 7(6):343-54. PubMed ID: 21654717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated necrotizing myopathy (NAM) related to SARS-Cov-2 infection: a case report.
    Ibrahim A; Ghazali WSW; Misyail A; Najwa L; Khan AH; Amir WM; Payus AO; Chao LW; Baharin J; Shahril NS; Yusoff SM; Aliaa W; Kee HF; Basri H
    BMC Neurol; 2023 Mar; 23(1):117. PubMed ID: 36949469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of autoantibodies for the diagnosis of autoimmune myopathies].
    Allenbach Y; Benveniste O
    Rev Neurol (Paris); 2013; 169(8-9):656-62. PubMed ID: 23642286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.